Wed, Oct 22, 2014, 10:53 AM EDT - U.S. Markets close in 5 hrs 7 mins


% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

borisbear64 4 posts  |  Last Activity: Oct 3, 2014 11:28 AM Member since: Nov 9, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • why then did we get passed up by J&J in favour of Allios? they were buying into a potential RSV vaccine why not us? This is important. ..and i suppose is echoed in the aguments about why we were passed over re Ebola (after all this a government led initiative and we NVAX is effectively governement funded).
    Is there a problem with the efficacy or science behind us?

  • De Masi did say publicly that he would not entertain an offer less than the IPO price so that original investors were made good....the IPO price was $11.50..
    IMO it is verry likely that a bid will be coming soon at this level...and with the pps sitting at 5 (in defiance of all the covering analysts)... De Masi would find it hard to refuse

  • Reply to

    Anyone out there?

    by srosone Aug 20, 2014 3:18 PM
    borisbear64 borisbear64 Aug 20, 2014 4:10 PM Flag

    Street article is just trying to suck in fresh $$ for the short sellers they represent to feed on. This stock IMO is a scam...a classic short selling pump stock. Still no revenue, no FDA hope of approval, gravy train management who dont ivest 1c of their own money ... pumps reverse splits, more pumps...eventually ch11. .and all is forgotten..and the criminaly backed short and naked short funds are never investigated.

  • borisbear64 by borisbear64 Jul 31, 2014 4:33 PM Flag

    it has alaways suprised me in the last few years why no serious t/over offer has materialised. Now the time is ripe. The predators who we know must have been eyeing up Gluu will pounce soon...

5.59+0.03(+0.54%)10:51 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.